|
6XDC
Cryo-EM structure of SARS-CoV-2 ORF3a
Deposited 2020-06-10
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–275(275 aa)
Chain B
1–275(275 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE;1 blot force, 5 second wait time, 3 second blot time
|
Resolution 2.90 Å
|
|
7KJR
Cryo-EM structure of SARS-CoV-2 ORF3a
Deposited 2020-10-26
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–275(275 aa)
Chain B
1–275(275 aa)
|
Not recorded
|
PEE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE;1 blot force
5 second wait time
3 second blot time
|
Resolution 2.08 Å
|
|
8EQJ
Structure of SARS-CoV-2 Orf3a in late endosome/lysosome-like membrane environment, MSP1D1 nanodisc
Deposited 2022-10-07
|
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–275(275 aa)
Chain B
1–275(275 aa)
|
Not recorded
|
PEE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine × 4
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.00 Å
|
|
8EQU
Structure of SARS-CoV-2 Orf3a in late endosome/lysosome-like environment, Saposin A nanodisc
Deposited 2022-10-09
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain A
1–275(275 aa)
Chain B
1–275(275 aa)
|
Not recorded
|
PEE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
8T5P
SARS-CoV-2 ORF3a peptide in complex with TRAF3 TRAF domain
Deposited 2023-06-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain G
36–40(5 aa)
Fragment:UNP residues 36-40
Chain H
36–40(5 aa)
Fragment:UNP residues 36-40
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;13% PEG3350, 0.1 M Tris, pH 8.0, 0.25 M ammonium sulfate
|
Resolution 2.50 Å
R-free 0.242
|
|
8T5P
SARS-CoV-2 ORF3a peptide in complex with TRAF3 TRAF domain
Deposited 2023-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain I
36–40(5 aa)
Fragment:UNP residues 36-40
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293.15 K;13% PEG3350, 0.1 M Tris, pH 8.0, 0.25 M ammonium sulfate
|
Resolution 2.50 Å
R-free 0.242
|
|
8T5Q
SARS-CoV-2 ORF3a peptide in complex with TRAF2 TRAF domain
Deposited 2023-06-14
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain G
36–40(5 aa)
Fragment:UNP residues 36-40
Chain H
36–40(5 aa)
Fragment:UNP residues 36-40
|
Not recorded
|
PG4 TETRAETHYLENE GLYCOL × 2
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;277.15 K;0.1 M sodium citrate, pH 5.0, 20% w/v PEG8000
|
Resolution 1.90 Å
R-free 0.240
|
|
8T5Q
SARS-CoV-2 ORF3a peptide in complex with TRAF2 TRAF domain
Deposited 2023-06-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain I
36–40(5 aa)
Fragment:UNP residues 36-40
|
Not recorded
|
PG4 TETRAETHYLENE GLYCOL × 2
PEG DI(HYDROXYETHYL)ETHER × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;277.15 K;0.1 M sodium citrate, pH 5.0, 20% w/v PEG8000
|
Resolution 1.90 Å
R-free 0.240
|
|
9RU5
Cryo-EM structure of TCRpub/pMHC
Deposited 2025-07-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain P
207–215(9 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4;30 mM HEPES pH 7.4, 150 mM NaCl
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.26 Å
|